Literature: open-access stability study

Enalapril 0.5 mg/mL oral suspension

Ingredients

IngredientRoleFor 100 mL
Enalapril maleateactive0.05 g
SuspendItvehicleq.s. to 100 mL
Strength
0.5 mg/mL
Starting material
Enalapril maleate bulk powder
Container
See the study
  • At 25 °C content fell to 88% by 90 days.

Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.

Storage and beyond-use date

StorageBUDBasis
Refrigerated180 daysCited stability study. Duration supported by the cited stability study for this formula, container, and storage.
Room temperature60 daysCited stability study. Duration supported by the cited stability study for this formula, container, and storage.

Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.

Ingredient checks

No FDA compounding list or NIOSH flags for the active ingredient.

Source

Mota S, Torres A, Quintas C, et al.. Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration. Pharmaceuticals (Basel). 2024;17(8):1052. PMID 39204157. PMC11359931. License: CC BY (checked 2026-11-06). Read the article · DOI

For licensed clinicians. Use with clinical judgment.